hotspot -WSS

hotspot

author：fashion 2025-09-09 19:28:32 - browse：19925

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.

The drug, a once-weekly injection known as CT-388, resulted in an average placebo-adjusted weight loss of 18.8% after 24 weeks, the company said. The study was a Phase 1 trial, though it was placebo-controlled.

The reaction to such an early result — Roche shares were up roughly 4% early Thursday — is a signal both of the stakes of the obesity medication race and the keen interest investors have in the field.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Why are elite athletes different? Take a look at their microbes

WSS

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Prosecutors say FTX founder Sam Bankman

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Florida babysitter arrested over hot car death, authorities say

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

explore

Walensky prepares to leave CDC — and Congress — behind

Paxlovid study fails to answer questions over benefit for broader groups

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

New chart reveals military’s vast involvement in Operation Warp Speed

What does generative AI mean for health care? We asked experts

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Supreme Court strikes down use of affirmative action

The science behind Janet Jackson's pregnancy at 49

hotspot

A former Republican legislative candidate has been charged for his role in the US Capitol riot

3 hurdles to bringing medical devices to the U.S. market

Donald Trump's relentless attacks on special counsel Jack Smith

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

New chief aims to remake Sanofi Genzyme

#NeedHerScience: shining a light on gender disparities in medicine

explore

entertainment

focus

hotspot